In agreement with antibody data, the frequencies of spike-specific B cells and CD4+ T cells significantly increased in naive individuals but not in individuals who have recovered from COVID-19 after the booster administration (Figure 6, D and E). The gene discussed is CD4; the disease is COVID-19.